ChromaDex (CDXC) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDXC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Why ChromaDex Corp (CDXC) Is Surging In 2025?March 25, 2025 | msn.comChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision ScienceMarch 19, 2025 | businesswire.comChromaDex's (CDXC) Buy Rating Reaffirmed at HC WainwrightMarch 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $2.69 Million Stock Position in ChromaDex Co. (NASDAQ:CDXC)March 18, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Trading Down 5.6% - Here's WhyMarch 14, 2025 | marketbeat.comChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025March 13, 2025 | businesswire.comQ1 Earnings Forecast for ChromaDex Issued By HC WainwrightMarch 12, 2025 | marketbeat.comChromaDex to Present at the 37th Annual Roth ConferenceMarch 11, 2025 | businesswire.comChromaDex price target raised to $11 from $8 at H.C. WainwrightMarch 10, 2025 | markets.businessinsider.comChromaDex (NASDAQ:CDXC) Stock Price Expected to Rise, HC Wainwright Analyst SaysMarch 10, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Stock Rating Lowered by StockNews.comMarch 7, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Shares Down 8.1% - What's Next?March 7, 2025 | marketbeat.comRoth Capital Increases Earnings Estimates for ChromaDexMarch 7, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Price Target Raised to $8.10 at LADENBURG THALM/SH SHMarch 6, 2025 | marketbeat.comChromaDex Capitalizes On Longevity Boom, But Valuation Remains HighMarch 6, 2025 | seekingalpha.comChromaDex Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextMarch 6, 2025 | finance.yahoo.comChromaDex (NASDAQ:CDXC) Sets New 52-Week High - Here's WhyMarch 6, 2025 | marketbeat.comQ4 2024 Chromadex Corp Earnings CallMarch 6, 2025 | uk.finance.yahoo.comChromaDex Reports Record Revenues Amid ChallengesMarch 5, 2025 | tipranks.comChromaDex Shares Rise After 4Q Earnings BeatMarch 5, 2025 | marketwatch.comChromaDex price target raised to $8.10 from $6.80 at LadenburgMarch 5, 2025 | markets.businessinsider.comChromadex (CDXC) Gets a Buy from Roth MKMMarch 5, 2025 | markets.businessinsider.comChromaDex (NASDAQ:CDXC) Releases Earnings Results, Beats Estimates By $0.01 EPSMarch 5, 2025 | marketbeat.comChromaDex Corporation (NASDAQ:CDXC) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | insidermonkey.comQ4 2024 Chromadex Corp Earnings Call TranscriptMarch 4, 2025 | gurufocus.comChromaDex Corporation (CDXC) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comChromaDex Corporation 2024 Q4 - Results - Earnings Call PresentationMarch 4, 2025 | seekingalpha.comChromaDex sees FY25 revenue growth roughly 18%March 4, 2025 | markets.businessinsider.comChromaDex reports Q4 EPS 9c, consensus 2cMarch 4, 2025 | markets.businessinsider.comChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 ResultsMarch 4, 2025 | businesswire.com218,528 Shares in ChromaDex Co. (NASDAQ:CDXC) Bought by Los Angeles Capital Management LLCMarch 2, 2025 | marketbeat.comChromaDex (CDXC) Projected to Post Earnings on WednesdayFebruary 26, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Upgraded to Strong-Buy at StockNews.comFebruary 25, 2025 | marketbeat.comChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025February 25, 2025 | businesswire.comShort Interest in ChromaDex Co. (NASDAQ:CDXC) Rises By 6.0%February 18, 2025 | marketbeat.comShould Weakness in ChromaDex Corporation's (NASDAQ:CDXC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?February 14, 2025 | finance.yahoo.comShould Weakness in ChromaDex Corporation's (NASDAQ:CDXC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?February 14, 2025 | finance.yahoo.com50,000 Shares in ChromaDex Co. (NASDAQ:CDXC) Acquired by Sargent Investment Group LLCFebruary 6, 2025 | marketbeat.comChromaDex Co. (NASDAQ:CDXC) Sees Large Increase in Short InterestFebruary 3, 2025 | marketbeat.comUS Growth Companies With High Insider Ownership January 2025January 24, 2025 | finance.yahoo.comBarclays PLC Grows Stock Position in ChromaDex Co. (NASDAQ:CDXC)January 21, 2025 | marketbeat.comShort Interest in ChromaDex Co. (NASDAQ:CDXC) Grows By 6.7%January 19, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Rating Lowered to "Buy" at StockNews.comJanuary 15, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average - Here's What HappenedJanuary 14, 2025 | marketbeat.comChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025January 6, 2025 | businesswire.comChromaDex (NASDAQ:CDXC) Shares Cross Above 200-Day Moving Average - Here's What HappenedJanuary 2, 2025 | marketbeat.comStockNews.com Upgrades ChromaDex (NASDAQ:CDXC) to "Strong-Buy"December 25, 2024 | marketbeat.comChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.comDecember 17, 2024 | marketbeat.comChromaDex Co. (NASDAQ:CDXC) Director Frank L. Jaksch, Jr. Sells 37,161 SharesDecember 14, 2024 | insidertrades.comFrank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) StockDecember 13, 2024 | marketbeat.com Get ChromaDex News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXC and its competitors with MarketBeat's FREE daily newsletter. Email Address CDXC Media Mentions By Week CDXC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXC News Sentiment▼0.000.90▲Average Medical News Sentiment CDXC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXC Articles This Week▼03▲CDXC Articles Average Week Get ChromaDex News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BHC News Today APLS News Today ARWR News Today VCEL News Today TWST News Today KNSA News Today RXRX News Today DNLI News Today NAMS News Today AGIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXC) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ChromaDex Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ChromaDex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDXC Stock Alerts